This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Horizon Technology Finance Provides Investment Portfolio Update For Third Quarter 2012

FARMINGTON, Conn., Oct. 1, 2012 (GLOBE NEWSWIRE) -- Horizon Technology Finance Corporation (Nasdaq:HRZN) (the "Company" or "Horizon"), a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services and clean-tech industries, today provided a portfolio update for the third quarter of 2012.

Gerald A. Michaud, President of Horizon, commented, "During the third quarter, we took advantage of the enhanced liquidity provided by our $30 million equity offering in July to increase investment activity for our fifth consecutive quarter. By funding a total of $48.5 million in new loans to eight existing portfolio companies and to four new companies, we have maintained our positive momentum in the marketplace and expanded our earning assets. The ongoing success we have achieved in sourcing attractive investment opportunities that meet our investment criteria has enabled Horizon to end the third quarter with a strong backlog of $32.8 million in unfunded commitments, which puts Horizon in a position for growth going forward. We expect our new equity, combined with our increased leverage from our new $75 million term loan facility, will allow us to maintain our focus on deploying capital in a disciplined manner and further expand our diverse high-quality portfolio."

New Loans Funded

Gross new loan investments during the third quarter of 2012 totaled $48.5 million. Less refinanced balances, net new loan investments totaled approximately $36.5 million. During the third quarter of 2012, Horizon provided funding to the following new and existing portfolio companies:

  • $4.0 million to Anacor Pharmaceuticals, Inc., an existing portfolio company. Anacor is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.
  • $3.3 million to Aquion Energy, Inc., an existing portfolio company. Aquion is a developer and manufacturer of Aqueous Hybrid Ion batteries and energy storage systems.
  • $1.7 million to Luxtera, Inc., an existing portfolio company. Luxtera is a developer of integrated silicon CMOS photonics.
  • $1.7 million to Mitralign, Inc., a new portfolio company. Mitralign is a developer of an innovative catheter based technology for percutaneous treatment of functional mitral regurgitation.
  • $15.0 million to Radisphere National Radiology Group, Inc., an existing portfolio company. Radisphere combines local radiologists who provide hands-on patient care and a large network of subspecialists to deliver faster, more accurate diagnoses, appropriate utilization, and a high quality of patient care for community hospitals, systems and ACOs.
  • $1.0 million to Recondo Technology, Inc., an existing portfolio company. Recondo is a software company that brings efficiencies and cost savings to healthcare payment processing by automating the revenue cycle and payment cycle, from pre-scheduling to adjudication, with virtually no manual intervention.
  • $5.0 million to SimpleTuition, Inc., a new portfolio company. SimpleTuition is an internet company offering tips, advice, interactive tools, and deals to ensure students plan better for the cost of college and pay less for college-related expenses.
  • $7.0 million to SolarBridge Technologies, Inc., a new portfolio company. SolarBridge is a leader in integrated microinverter technologies for the solar industry, accelerating the adoption of solar energy for residential and commercial use.
  • $3.0 million to Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS), an existing portfolio company. Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics.
  • $0.3 million to Xcovery Holding Company LLC, an existing portfolio company. Xcovery is dedicated to advancing next generation targeted therapeutics as promising new treatments to improve the lives of cancer patients.
  • $6.0 million to Xtreme Power, Inc., a new portfolio company. Xtreme Power provides scalable, real-time power management and energy storage solutions that enable a more sustainable, reliable and cost-effective electric grid.
  • $0.5 million to an existing portfolio company which delivers digital commerce services that embrace emerging technologies to create exceptional branded experiences.

Commitments

During the quarter ended September 30, 2012, Horizon closed new loan commitments totaling $41.3 million to six companies, compared to the quarter ended June 30, 2012, wherein Horizon closed new loan commitments totaling $60.0 million to 11 companies.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs